Elena Cattaneo is Director of the Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases at the Department of Pharmacological Sciences, as well as a co-founder and first appointed Director of UniStem, the Centre for Stem Cell Research of the University of Milano. The main research theme of her lab is neural stem cells, and the molecular pathophysiology of Huntington’s Disease.
For over twenty years Elena Cattaneo and her team studied Huntington disease with the aim of contributing to achieve a full understanding of its pathogenic mechanisms and to develop pharmacological, genic and cellular strategies that can interfere with the disease.
In 2013 Elena Cattaneo was appointed by the Italian government as ‘Senator for Life for scientific and social merits’. Since then she continues to lead her lab, while taking part into transcontinental, European and national research consortia.
Pietro De Camilli
Pietro De Camilli
Pietro De Camilli is professor of Neuroscience and Cell Biology at Yale University (USA) and investigator at the Howard Hughes Medical Institute. De Camilli is also the director of the Kavli Institute of Neuroscience at the Yale University School of Medicine.
Pietro De Camilli and his team are interested in the mechanisms underlying the dynamics of cell membranes with emphasis on their role in neuronal physiology. More specifically, De Camilli and his team focus on membrane traffic reactions associated with the release of fast-acting neurotransmitters via synaptic vesicles.
In addition, the team investigates how disruption of some of these mechanisms results in neurodegenerative diseases, including Parkinson’s disease.
Marta Nieto López is principal investigator at the Centro Nacional de Biotecnologia (Spain) and group leader of the ‘Cerebral Cortical Development’ lab. Marta and her team aim to define the cellular and molecular mechanisms that govern the generation of neurons and circuits of the mammalian cerebral cortex.
In collaboration with other research groups, they study models of cell migration. Her research provides basic knowledge of the mechanisms of neural specification and circuit formation, the potential programs of reprogramming neurons, and the specific advantages and plasticity of the human brain.
João Relvas is principal investigator at i3S (Instituto de Investigação e Inovação em Saúde – PT) where he leads a research group that studies the glial cells, a set of cells in the nervous system that have essential functions in maintaining the homeostasis of the nervous system. He is also part of the i3S Board of Directors and Coordinator of Neurobiology and Neurologic Disorders Program.
Karen Duff is a leader in the field of neurodegenerative disease. Has worked for over 30 years on Alzheimer’s disease and the tauopathies, for which she was awarded the prestigious Potamkin Prize in 2006. Her interests span a range of research areas, from discovery science through to therapeutic approaches.
Currently is director of the UK Dementia Research Institute leading a dynamic and ambitious programme of multidisciplinary and clinically-orientated research.